The National Health Insurance Authority (NHIA) and key NHIS stakeholders have held a 2 day stakeholders’ forum to review the NHIS Medicines List after a comprehensive market survey conducted for the 517 medicines currently on the NHIS Medicines List. A technical committee is set to finalize work on the new Medicines List and prices.
The Stakeholder meeting brought together representatives from the Ministry of Health, Medical Practitioners, Administrators of Provider facilities, Chamber of Pharmacy, Christian Health Association of Ghana (CHAG), Food & Drugs Authority, drug manufacturing companies and suppliers of drugs amongst others.
The event was chaired by Mrs. Martha Lutterodt, Director of Pharmaceutical Services, (MOH) on behalf of the Minister of Health.
Mrs. Lutterodt underscored the importance of the event as an annual statutory requirement that sought to create a platform for dialogue on the prices of medicines in order to determine realistic prices for medicines and ensure a sustainable health delivery system in the country.
“The NHIS is a national asset and belongs to all of us therefore we must ensure that the prices they pay for medicines are realistic as it impacts directly on the sustainability of the scheme. The scheme remains vital to families in both urban and rural areas and must be safeguarded” she said.
The Director of Provider Payment at the NHIA, Mr. Anthony Gingong, in his opening remarks emphasized how the NHIA valued the cordial relationship it has with its stakeholders and the need for regular and timely review of medicines list and prices. He acknowledged the positive contributions of stakeholders in the Medicines List review process which seeks to align tariffs with market conditions.
The new NHIS Medicines List and prices for 2017 is subject to approval by the Ministry of Health and will be announced when the process is completed.